Cycling allows receptors to recover and can help separate actual benefit from temporary adaptation
Tirzepatide works similarly to semaglutide but targets both GLP-1 and GIP receptors, which can lead to even greater average weight loss in studies (up to 20-21%) when combined with lifestyle changes
Dose: The Victoza pen can deliver doses of 0.6 mg, 1.2 mg, or 1.8 mg
Its primary use is for the treatment of major depressive disorder and seasonal affective disorder, but it is also prescribed off-label for smoking cessation, ADHD, and as an adjunct in weight management strategies
The heterogeneity in study designs, probiotic strains used, dosages, treatment durations, and participant populations makes it difficult to draw firm conclusions